Erschienen in:
16.09.2017 | Guidelines
RSSDI clinical practice recommendations for diagnosis, prevention, and control of the diabetes mellitus-tuberculosis double burden
verfasst von:
Vijay Viswanathan, Sarita Bajaj, Sanjay Kalra, Sameer Aggarwal, Atulya Atreja, Dhruva Chaudhry, D. J. Christopher, A. K. Das, Sujoy Ghosh, Jubbin Jacob, Anil Kapur, M. V. Ajay Kumar, Satyavani Kumpatla, S. V. Madhu, B. M. Makkar, Salam Ranabir, Rakesh Sahay, P. K. Thomas, Mangesh Tiwaskar, Srikanth Tripathy, Zarir Udwadia, Sunny Virdi, Nevin Wilson
Erschienen in:
International Journal of Diabetes in Developing Countries
|
Ausgabe 4/2017
Einloggen, um Zugang zu erhalten
Excerpt
The International Diabetes Federation (IDF) estimates for 2015 revealed that 8.8% of the world’s population had diabetes mellitus (DM) and with 69.2 million people with DM, India ranked second in the world [
1]. Globally, 10.4 million new cases of tuberculosis (TB) were estimated to have occurred in 2015 with India, Indonesia, China, Nigeria, Pakistan, and South Africa accounting for 60% of them [
2]. There exists a strong epidemiological evidence base demonstrating the coexistence of DM and TB [
3‐
8]. This association between a globally prevalent non-communicable disease such as DM and a serious infectious disease (TB), endemic in developing nations is known to adversely impact the course of progression and treatment outcome for both diseases and is transforming into a “syndemic” necessitating synergistic management [
4,
5,
9,
10]. A recently published systematic review identified several risk factors associated with the DM-TB comorbidity that included older age, sedentary occupation, cigarette smoking, alcohol consumption, both lower and higher body mass index (BMI), human immunodeficiency virus (HIV) co-infection, weight loss, hypertension, and familial history of DM or TB [
11]. …
